|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | |||||||||||||||||||
| Accounts receivable | |||||||||||||||||||
| Costs in excess of billings | |||||||||||||||||||
| Prepaid expenses | |||||||||||||||||||
| Total Current Assets | |||||||||||||||||||
| Total Assets | |||||||||||||||||||
| Accounts payable and accrued expense | |||||||||||||||||||
| Accrued compensation | |||||||||||||||||||
| Contract liabilities | |||||||||||||||||||
| Notes payable - related party | |||||||||||||||||||
| Convertible notes payable - related party, net | |||||||||||||||||||
| Notes payable | |||||||||||||||||||
| Convertible note payable, net | |||||||||||||||||||
| Advances payable - related party, net | |||||||||||||||||||
| Derivative liability | |||||||||||||||||||
| Total Current Liabilities | |||||||||||||||||||
| Convertible notes payable due after one year, net | |||||||||||||||||||
| Total Liabilities | |||||||||||||||||||
| Commitments and contingencies (See Note 7) | |||||||||||||||||||
| Common stock, $0.001 par value; 200,000,000 shares authorized, 190,012,124 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||||||||||||||
| Common and preferred stock subscribed | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total Stockholders' Deficit | |||||||||||||||||||
| Total Liabilities and Stockholders' Deficit | |||||||||||||||||||
| Preferred stock, value | |||||||||||||||||||
| Series B Preferred Stock | |||||||||||||||||||
| Series C Preferred Stock | |||||||||||||||||||
| Series D Preferred Stock | |||||||||||||||||||
Loading...
